Multiphase multi-detector row computed tomography in the setting of chronic liver disease and orthotopic liver transplantation: Can a series be eliminated in order to reduce radiation dose?

Journal of Computer Assisted Tomography

Volumn 37, Issue 3, 2013, Pages 408-414

  Luke, Frank E ^a,b   Allen, Brian C ^a,c   Moshiri, Sara T ^a,d   Ho, Lisa M ^a   Massey, Christopher M ^a,e   Stinnett, Sandra S ^a   Muir, Andrew J ^f   Jaffe, Tracy A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

^c WAKE FOREST BAPTIST HEALTH   (United States)

^d GMC General Diagnostic Radiology   (United States)

^e DXP Imaging   (United States)

^f NONE

Author keywords

chronic liver disease; hepatocellular carcinoma; liver transplantation; radiation dose; surveillance

Indexed keywords

DIAGNOSIS; DOSIMETRY;

CHRONIC LIVER DISEASE; CT PROTOCOL; EFFECTIVE DOSE; HEPATOCELLULAR CARCINOMA; LIVER CT; LIVER TRANSPLANTATION; MULTIDETECTOR ROW COMPUTED TOMOGRAPHY; MULTIPHASES; ORTHOTOPIC LIVER TRANSPLANTATION; SURVEILLANCE;

COMPUTERIZED TOMOGRAPHY;

IOPAMIDOL;

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; AUTOIMMUNE DISEASE; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER RISK; CANCER SCREENING; CANCER SIZE; CANCER SURGERY; CHEMOEMBOLIZATION; COMPUTED TOMOGRAPHY SCANNER; CONTRAST ENHANCEMENT; DOSIMETRY; FEMALE; FOLLOW UP; HEALTH SURVEY; HEPATITIS B; HEPATITIS C; HUMAN; IMAGE ANALYSIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; NONALCOHOLIC FATTY LIVER; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; RADIATION DOSE REDUCTION; RADIATION RESPONSE; SARCOIDOSIS;

EID: 84878851137     PISSN: 03638715     EISSN: 15323145     Source Type: Journal    
DOI: 10.1097/RCT.0b013e3182838680     Document Type: Article

References (22)

1. Stefaniuk P, Cianciara J, Wiercinska-Drapalo A. Present and future possibilities for early diagnosis of hepatocellular carcinoma. World J Gastroenterol. 2010;16:418-424.
2. Starley BQ, Calcagno CJ, Harrison SA. Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology. 2010;51:1820-1832.
3. Bruix J, Sherman M. AASLD Practice guideline: management of hepatocellular carcinoma: an update. Gastroenterology; 2010:1-35.
4. Kim YK, Kim CS, Chung GH, et al. Comparison of gadobenate dimeglumineYenhanced dynamic MRI and 16-MDCT for the detection of hepatocellular carcinoma. AJR Am J Roentgenol. 2006;186:149-157.
5. Marin D, Di Martino M, Guerrisi A, et al. Hepatocellular carcinoma in patients with cirrhosis: qualitative comparison of gadobenate dimeglumineYenhanced MR imaging and multiphasic 64-section CT. Radiology. 2009;251:85-95.
6. Di Martino M, Marin D, Guerrisi A, et al. Intraindividual comparison of gadoxetate disodiumYenhanced MR imaging and 64-section multidetector CT in the detection of hepatocellular carcinoma in patients with cirrhosis. Radiology. 2010;256:806-816.
7. El-Serag HB, Marrero JA, Rudolph L, et al. Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology. 2008;134:1752-1763.
8. Monzawa S, Ichikawa T, Nakajima H, et al. Dynamic CT for detecting small hepatocellular carcinoma: usefulness of delayed phase imaging. AJR Am J Roentgenol. 2007;188:147-153.
9. Lim JH, Choi D, Kim SH, et al. Detection of hepatocellular carcinoma: value of adding delayed phase imaging to dual-phase helical CT. AJR Am J Roentgenol. 2002;179:67-73.
10. Iannaccone R, Laghi A, Catalano C, et al. Hepatocellular carcinoma: role of unenhanced and delayed phase multi-detector row helical CT in patients with cirrhosis. Radiology. 2005;234:460-467.
11. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208-1236.
12. HudaW, Ogden KM, Khorasani MR. Converting dose-length product to effective dose at CT. Radiology. 2008;248:995-1003.
13. Sunshine JH, Cypel YS. Types of procedures performed by diagnostic radiology practices: past patterns and future directions. AJR Am J Roentgenol. 2004;183:1193-1201.
14. Doyle DJ, O'Malley ME, Jang HJ, et al. Value of the unenhanced phase for detection of hepatocellular carcinomas 3 cm or less when performing multiphase computed tomography in patients with cirrhosis. J Comput Assist Tomogr. 2007;31:86-92.
15. Brenner DJ, Elliston CD. Estimated radiation risks potentially associated with full-body CT screening. Radiology. 2004;232:735-738.
16. Dixon AK, Dendy P. Spiral CT: how much does radiation dose matter? Lancet. 1998;352:1082-1083.
17. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334:693-699.
18. Sala M, Varela M, Bruix J. Selection of candidates with HCC for transplantation in the MELD era. Liver Transpl. 2004;10:S4-S9.
19. Shetty K, Timmins K, Brensinger C, et al. Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome. Liver Transpl. 2004;10:911-918.
20. Aberg F, Pukkala E, Hockerstedt K, et al. Risk of malignant neoplasms after liver transplantation: a population-based study. Liver Transpl. 2008;14:1428-1436.
21. Jiang Y, Villeneuve PJ, Fenton SS, et al. Liver transplantation and subsequent risk of cancer: findings from a Canadian cohort study. Liver Transpl. 2008;14:1588-1597.
22. El-Masry M, Puig CA, Saab S. Recurrence of non-viral liver disease after orthotopic liver transplantation. Liver Int. 2011;31:291-302.